Cargando…
Iron Chelator DIBI Suppresses Formation of Ciprofloxacin-Induced Antibiotic Resistance in Staphylococcus aureus
Antibiotic resistance of bacterial pathogens results from their exposure to antibiotics and this has become a serious growing problem that limits effective use of antibiotics. Resistance can arise from mutations induced by antibiotic-mediated damage with these mutants possessing reduced target sensi...
Autores principales: | Allan, David S., Holbein, Bruce E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687013/ https://www.ncbi.nlm.nih.gov/pubmed/36421286 http://dx.doi.org/10.3390/antibiotics11111642 |
Ejemplares similares
-
Novel Iron-Chelator DIBI Inhibits Staphylococcus aureus Growth, Suppresses Experimental MRSA Infection in Mice and Enhances the Activities of Diverse Antibiotics in vitro
por: Parquet, Maria del Carmen, et al.
Publicado: (2018) -
Anti-Inflammatory Effects of the Iron Chelator, DIBI, in Experimental Acute Lung Injury
por: Lehmann, Christian, et al.
Publicado: (2022) -
Antimicrobial Activity of the Iron-Chelator, DIBI, against Multidrug-Resistant Canine Methicillin-Susceptible Staphylococcus pseudintermedius: A Preliminary Study of Four Clinical Strains
por: Nocera, Francesca Paola, et al.
Publicado: (2022) -
Iron Withdrawal with DIBI, a Novel 3-Hydroxypyridin-4-One Chelator Iron-Binding Polymer, Attenuates Macrophage Inflammatory Responses
por: Ghassemi-Rad, Javad, et al.
Publicado: (2023) -
Comparison of Treatment Effects of Different Iron Chelators in Experimental Models of Sepsis
por: Lehmann, Christian, et al.
Publicado: (2021)